Tafamidis Reduces Death and Hospitalization for Acute Heart Failure in Octogenarian Patients With Transthyretin Cardiac Amyloidosis: A Propensity Score–Weighted Cohort Study
Tafamidis led to a lower mortality rate and fewer hospital readmissions for acute heart failure in octogenarian patients with transthyretin cardiac amyloidosis.
Authors
- Marie Laurent (ORCID: https://orcid.org/0000-0002-6484-1277)
- Louise Zmuda
- Florence Canouï‐Poitrine (ORCID: https://orcid.org/0000-0001-9970-6051)
- Mounira Kharoubi (ORCID: https://orcid.org/0000-0001-8942-2506)
- Thibaud Damy (ORCID: https://orcid.org/0000-0003-4058-3848)
- Amaury Broussier (ORCID: https://orcid.org/0000-0003-1137-9864)
- Frédéric Roca (ORCID: https://orcid.org/0000-0001-6026-9958)
- Emmanuel Teíger (ORCID: https://orcid.org/0000-0001-7515-4344)
- Silvia Oghina (ORCID: https://orcid.org/0000-0003-0108-5598)
- Emmanuelle Boutin
- Amira Zaroui (ORCID: https://orcid.org/0000-0002-4827-4057)
Institutions
- Inserm (FR)
- Université Paris-Est Créteil (FR)
- Normandie Université (FR)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Institut Mondor de Recherche Biomédicale (FR)
- Université de Rouen Normandie (FR)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1161/jaha.125.042330
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00